SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 784.45-0.4%Nov 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (1706)1/30/2015 12:26:51 AM
From: Miljenko Zuanic   of 3559
 
Thanks, saw that.
NVS seams confident, and it may be small incremental improvement (single chain small antibody), but next significant improvement in AMD (and DME) space would be VEGF-PDGF combo in single IV-i (or single vector gen therapy).

RE: Precision medicine Friday meeting, Y spelled it correctly at JPM...separate and identify small signal in huge gen-info noise! Much easy to say than do! REGN is already deep into it at their Genomic Center.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News